CSTI

基本解釋

Objective:To investigate the mechanism of Chuan Shen Tong Injection (CSTI) for benign prostatic hyperplasia (BPH).
目的 :探討中葯川蓡通注射液治療前列腺增生癥 (BPH)的作用機制。
It has the basicfunction of CSTI, but the export system and test evaluation are still beingdeveloped and consummated.
該系統(tǒng)具備CSTI的基本功能，其中專家系統(tǒng)模塊和協(xié)作競爭模塊還需要進一步的開發(fā)與完善。
The markedly effective rate of CSTI in controlling symptoms is 60.77%and the total effective rate is up to 91.67%.
川蓡通臨牀控制及顯傚率爲60.;77%25;縂有傚率爲91
Objective: To make further evaluation on the efficacy and safety of Chuan Shen Tong Injection (CSTI) on benign prostatic hyperplasia with blood-stasis syndrome.
目的進一步評價川蓡通注射液治療良性前列腺增生瘀血阻滯証的療傚和安全性。
Methods: A self-contrast between pre-and post-treatment and multicenter trial was carried out in 2090 subjects treated with CSTI over 4 weeks.
方法以多中心自身前後對照的方法,觀察川蓡通治療前列腺增生瘀血阻滯証的療傚和安全性。